Grifols Australia Pty Ltd
Regulatory activities for this sponsor.
Loading...
Sponsor content
13 result(s) found, displaying 1 to 10
-
Cancellation by sponsorRequested by Grifols Australia Pty Ltd
-
Cancellation by sponsorRequested by Grifols Australia Pty Ltd
-
Australian Public Assessment Report (AusPAR)AusPAR for Xembify (human normal immunoglobulin) for the treatment of primary immunodeficiency diseases.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Grifols Australia Pty Ltd - General laboratoryware IVDs.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Grifols Australia Pty Ltd - Instrument/analyser IVDs.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Grifols Australia Pty Ltd - Analyser software IVDs.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Grifols Australia Pty Ltd - Immunohaematology blood grouping antisera IVDs.
-
Australian Public Assessment Report (AusPAR)Australian Public Assessment Report for Alpha-1 proteinase inhibitor
-
Cancellation by sponsorRequested by Grifols Australia Pty Ltd
-
INTRATECT 5% 1g in 20 mL human normal immunoglobulin solution for intravenous infusion vial (164550)
ARTGAustralian Register of Therapeutic Goods (ARTG) information for INTRATECT 5% 1g in 20 mL human normal immunoglobulin solution for intravenous infusion vial.